Stem cells and diabetes treatment

APMIS

Volumn 113, Issue 11-12, 2005, Pages 858-875

  Madsen, Ole Dragsbæk ^a  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

cell; Cell therapy; Diabetes; Directed differentiation; Embryonic stem cell; Insulin; MAPC; Pancreas development; Stem cell

Indexed keywords

INSULIN;

ADOPTIVE IMMUNOTHERAPY; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL REGENERATION; CELL SURVIVAL; CLONOGENIC ASSAY; DIABETES CONTROL; EMBRYO DEVELOPMENT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SYNTHESIS; INSULIN TREATMENT; INSULINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ONTOGENY; ORGAN DONOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; ANIMAL; BIOLOGICAL MODEL; CELL LINEAGE; CYTOLOGY; DIABETES MELLITUS; FEMALE; METHODOLOGY; PHYSIOLOGY; PREGNANCY; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; PREGNANCY; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33645468639     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2005.apm_418.x     Document Type: Review

References (154)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 8.
2. Hellerström C. The life story of the pancreatic beta cell. Diabetologia 1984 26 : 393 400.
3. Orci L. The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited. Diabetologia 1985 28 : 528 46.
4. Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004 47 : 581 9.
5. Lernmark A, Falorni A. Immune phenomena and events in the islets in insulin-dependent diabetes mellitus. In : Pickup JC, Williams G editors. Textbook of Diabetes. Oxford : Blackwell Science Ltd, 1998 : 15.1 15.23.
6. Meier J, Bhushan A, Butler A, Rizza R, Butler P. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005 48 : 2221 8.
7. Sutherland DE, Sibley R, Xu XZ, Michael A, Srikanta AM, Taub F, et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians 1984 97 : 80 7.
8. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1997 88 : 561 72.
9. Scaglia L, Smith FE, Bonner-Weir S. Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology 1995 136 : 5461 8.
10. Blume N, Skouv J, Larsson LI, Holst JJ, Madsen OD. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest 1995 96 : 2227 35.
11. Klöppel G, Löhr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985 4 : 110 25.
12. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003 52 : 102 10.
13. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science 2005 307 : 380 4.
14. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994 3 : 299 303.
15. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999 48 : 150 7.
16. Bonner-Weir S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 2000 141 : 1926 9.
17. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol 2000 24 : 297 302.
18. Bouwens L, Rooman I. Regulation of pancreatic beta-cell mass. Physiol Rev 2005 85 : 1255 70.
19. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004 429 : 41 6.
20. Bock T, Pakkenberg B, Buschard K. Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 2003 52 : 1716 22.
21. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993 42 : 1715 20.
22. Bonner-Weir S, Weir GC. New sources of pancreatic beta-cells. Nat Biotech 2005 23 : 857 61.
23. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998 41 : 629 33.
24. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001 50 : 1 11.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 86.
26. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 : 837 53.
27. Björk S. The costs of diabetes and diabetes care: international studies. In : Williams R, Tuomilehto J, Björk S editors. The Economics of Diabetes Care. Oxford : Blackwell Science Ltd., 2000 : 17 24.
28. Zimmet PZ, McCarty DJ, de Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications 1997 11 : 60 8.
29. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001 50 : 710 9.
30. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002 51 : 2148 57.
31. Shapiro AM, Nanji SA, Lakey JR. Clinical islet transplant: current and future directions towards tolerance. Immunol Rev 2003 196 : 219 36.
32. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 9.
33. Robertson RP, Lanz KJ, Sutherland DER, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes 2001 50 : 47 50.
34. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002 346 : 1692 8.
35. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005 352 : 2598 608.
36. Bonner-Weir S, Sharma A. Pancreatic stem cells. J Pathol 2002 197 : 519 26.
37. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000 6 : 278 82.
38. Sachs DH, Bonner-Weir S. New islets from old. Nat Med 2000 6 : 250 1.
39. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000 97 : 7999 8004.
40. Gao R, Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 2003 52 : 2007 15.
41. Rescan C, Le Bras S, Lefebvre VH, Frandsen U, Klein T, Foschi M, et al. EGF-induced proliferation of adult human pancreatic duct cells is mediated by the MEK/ERK cascade. Lab Invest 2005 85 : 65 74.
42. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD. mRNA profiling of rat islet tumors reveals Nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J Biol Chem 1996 271 : 18749 58.
43. Oster A, Jensen J, Serup P, Galante P, Madsen OD, Larsson LI. Rat endocrine pancreatic development in relation to two homeobox gene products (Pdx-1 and Nkx 6.1). J Histochem Cytochem 1998 46 : 707 16.
44. Gradwohl G, Dierich A, LeMeur M, Guillemot F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 2000 97 : 1607 11.
45. Heremans Y, Van De Casteele M, in't Veld P, Gradwohl G, Serup P, Madsen O, et al. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol 2002 159 : 303 12.
46. Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, Aye T, et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes 2004 5 : 16 22.
47. Herrera PL. Transgenic tagging defining pancreatic pedigrees. Ann NY Acad Sci 2004 1014 : 38 49.
48. Gannon M, Herrera PL, Wright CVE. Mosaic Cre-mediated recombination in pancreas using the pdx-1 enhancer/promoter. Genesis 2000 26 : 143 4.
49. Kawaguchi Y, Cooper B, Gannon M, Ray M, MacDonald RJ, Wright CVE. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. 2002 32 : 128 34.
50. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002 129 : 2447 57.
51. Lee CS, De Leon DD, Kaestner KH, Stoffers DA. Regeneration of pancreatic islets after partial pancreatectomy in mice does not involve the reactivation of neurogenin-3. Diabetes 2005 RM, Smukler SR, Kieffer TJ, Enikolopov G, Asghar Z, Wheeler MB, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotech 2004 22 : 1115 24.
52. Suzuki A, Nakauchi H, Taniguchi H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 2004 53 : 2143 52.
53. Means AL, Meszoely IM, Suzuki K, Miyamoto Y, Rustgi AK, Coffey RJ Jr., et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 2005 132 : 3767 76.
54. Baeyens L, De Breuck S, Lardon J, Mfopou JK, Rooman I, Bouwens L. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 2005 48 : 49 57.
55. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004 306 : 2261 4.
56. Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001 50 : 521 33.
57. Lechner A, Nolan AL, Blacken RA, Habener JF. Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem Biophys Res Commun 2005 327 : 581 8.
58. Brazelton TR, Rossi FMV, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000 290 : 1775 9.
59. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000 290 : 1779 82.
60. Vogel G. Cell biology. Stem cells: new excitement, persistent questions. Science 2000 290 : 1672 4.
61. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002 418 : 41 9.
62. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003 422 : 897 901.
63. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003 422 : 901 4.
64. Medvinsky A, Smith A. Stem cells: Fusion brings down barriers. Nature 2003 422 : 823 5.
65. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004 116 : 639 48.
66. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003 111 : 843 50.
67. Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, Mochizuki H, et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003 46 : 1366 74.
68. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL, Habener JF. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004 53 : 616 23.
69. Taneera J, Rosengren A, Renstrom E, Nygren JM, Serup P, Rorsman P, et al. Failure of transplanted bone marrow cells to adapt a pancreatic beta-cell fate. Diabetes 2006 in press.
70. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003 2 : 763 70.
71. Ulloa-Montoya F, Verfaillie CM, Hu WS. Culture systems for pluripotent stem cells. J Biosci Bioeng 2005 100 : 12 27.
72. Toma JG, Akhavan M, Fernandes KJL, Barnabe-Heider F, Sadikot A, Kaplan DR, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001 3 : 778 84.
73. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004 117 : 2971 81.
74. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004 200 : 123 35.
75. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005 115 : 326 38.
76. Kues WA, Petersen B, Mysegades W, Carnwath JW, Niemann H. Isolation of murine and porcine fetal stem cells from somatic tissue. Biol Reprod 2005 72 : 1020 8.
77. Eckfeldt CE, Mendenhall EM, Verfaillie CM. The molecular repertoire of the 'almighty' stem cell. Nat Rev Mol Cell Biol 2005 6 : 726 37.
78. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981 292 : 154 6.
79. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981 78 : 7634 8.
80. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998 282 : 1145 7.
81. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988 336 : 688 90.
82. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001 17 : 435 62.
83. Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 2004 23 : 7150 60.
84. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004 10 : 55 63.
85. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005 6 : 872 81.
86. Dewey MJ, Martin DW, Martin GR, Mintz B. Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A. 1977 74 : 5564 8.
87. Deltour L, Leduque P, Paldi A, Ripoche MA, Dubois P, Jami J. Polyclonal origin of pancreatic islets in aggregation mouse chimaeras. Development 1991 112 : 1115 21.
88. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005 19 : 1129 55.
89. Pera MF, Trounson AO. Human embryonic stem cells: prospects for development. Development 2004 131 : 5515 25.
90. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001 19 : 193 204.
91. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001 292 : 1389 94.
92. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002 99 : 16105 10.
93. Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 2003 100 : 998 1003.
94. Miyazaki S, Yamato E, Miyazaki J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 2004 53 : 1030 7.
95. Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J, et al. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci U S A 1993 90 : 527 31.
96. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA. Insulin staining of ES cell progeny from insulin uptake. Science 2003 299 : 363.
97. Hansson M, Tonning A, Frandsen U, Petri A, Rajagopal J, Englund MCO, et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 2004 53 : 2603 9.
98. Soria B, Roche E, Berna G, Leon-Quinto T, Reig J, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000 49 : 157 62.
99. Kahan BW, Jacobson LM, Hullett DA, Ochoada JM, Oberley TD, Lang KM, et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 2003 52 : 2016 24.
100. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001 50 : 1691 7.
101. Brolen GKC, Heins N, Edsbagge J, Semb H. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing b-cell-like cells. Diabetes 2005 54 : 2867 74.
102. Wichterle H, Lieberam I, Porter J, Jessell T. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002 110 : 385 97.
103. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 2004 101 : 12543 8.
104. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000 6 : 568 72.
105. Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci U S A 2003 100 : 7253 8.
106. Horb ME, Shen CN, Tosh D, Slack JMW. Experimental conversion of liver to pancreas. Curr Biol 2003 13 : 105 15.
107. Zalzman M, Anker-Kitai L, Efrat S. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes 2005 54 : 2568 75.
108. Sapir T, Shternhall K, Meivar-Levy I, Blumenfeld T, Cohen H, Skutelsky E, et al. Cell-replacement therapy for diabetes: generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A 2005 102 : 7964 9.
109. Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, et al. Glucose-dependent insulin release from genetically engineered K cells. Science 2000 290 : 1959 62.
110. Slack J. Developmental biology of the pancreas. Development 1995 121 : 1569 80.
111. Wells JM, Melton DA. Vertebrate endoderm development. Annu Rev Cell Dev Biol 1999 15 : 393 410.
112. Grapin-Botton A, Melton DA. Endoderm development: from patterning to organogenesis. Trends Genet 2000 16 : 124 30.
113. Scharfmann R. Control of early development of the pancreas in rodents and humans: implications of signals from the mesenchyme. Diabetologia 2000 43 : 1083 92.
114. Edlund H. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat Rev Genet 2002 3 : 524 32.
115. Murtaugh LC, Melton DA. Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol 2003 19 : 71 89.
116. Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 2004 47 : 597 613.
117. Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn 2004 229 : 176 200.
118. Madsen OD, Serup P, Jensen J, Petersen HV, Heller RS. An historical and phylogenetic perspective of islet-cell development. In : Habener JF, Hussain MA editors. Molecular Basis of Pancreas Development and Function. Norwell, Massachusetts : Kluwer Academic Publishers, 2001 : 1 17.
119. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994 371 : 606 9.
120. Offield M, Jetton T, Labosky P, Ray M, Stein R, Magnuson M, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996 122 : 983 95.
121. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997 15 : 106 10.
122. Yasunaga M, Tada S, Torikai-Nishikawa S, Nakano Y, Okada M, Jakt LM, et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotech 2005 23 : 1542 50.
123. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotech 2005 23 : 1534 41.
124. Bhushan A, Itoh N, Kato S, Thiery JP, Czernichow P, Bellusci S, et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001 128 : 5109 17.
125. Hald J, Hjorth JP, German MS, Madsen OD, Serup P, Jensen J. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev Biol 2003 260 : 426 37.
126. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000 24 : 36 44.
127. Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist-Forbes E, et al. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care 2003 26 : 2231 7.
128. Blaha P, Bigenzahn S, Koporc Z, Sykes M, Muehlbacher F, Wekerle T. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation 2005 80 : 237 43.
129. Madsen OD, Andersen LC, Michelsen B, Owerbach D, Larsson LI, Lernmark Å, et al. Tissue-specific expression of transfected human insulin genes in pluripotent clonal rat insulinoma lines induced during passage in vivo. Proc Natl Acad Sci U S A 1988 85 : 6652 6.
130. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996 384 : 458 60.
131. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996 384 : 455 8.
132. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997 17 : 138 9.
133. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, et al. Mutation in hepatocyte nuclear factor-1b gene (TCF2) associated with MODY. Nat Genet 1997 17 : 384 5.
134. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999 23 : 323 8.
135. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992 356 : 162 4.
136. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001 345 : 971 80.
137. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998 391 : 900 4.
138. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002 283 : E413 422.
139. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004 114 : 908 16.
140. Brady MJ. IRS2 takes center stage in the development of type 2 diabetes. J Clin Invest 2004 114 : 886 8.
141. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol cell 2000 6 : 87 97.
142. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999 96 : 329 39.
143. Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K, Stoffel M, et al. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in bIRKO mice. Am J Physiol Endocrinol Metab 2004 286 : E41 49.
144. Swenne I. Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 1992 35 : 193 201.
145. Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res 2004 : 747 54.
146. Larsen PJ, Holst JJ. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. Regul Pept 2005 128 : 97 107.
147. Brubaker PL, Drucker DJ. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004 145 : 2653 9.
148. Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A. Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 2005 54 : 2596 601.
149. Rooman I, Bouwens L. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia 2004 47 : 259 65.
150. Suarez-Pinzon WL, Lakey JRT, Brand SJ, Rabinovitch A. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet b-cells from pancreatic duct cells and an increase in functional beta-cell mass. J Clin Endocrinol Metab 2005 90 : 3401 9.
151. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y, et al. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotech 2005 23 : 1274 82.
152. Madsen OD, Kaestner KH. Antibodies to islet cell surface markers. Curr Med Chem - Immunology, Endocrine & Metabolic Agents 2004 4 : 309 13.
153. Mellitzer G, Martin M, Sidhoum-Jenny M, Orvain C, Barths J, Seymour PA, et al. Pancreatic islet progenitor cells in neurogenin 3-yellow fluorescent protein knock-add-on mice. Mol Endocrinol 2004 18 : 2765 76.
154. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001 14 : 417 24.